The oncogenic properties of podoplanin were confirmed in human oral SCC cell lines expressing endogenous podoplanin, as its knockdown significantly reduced the tumorigenic capacities of HN2 and HN5 oral carcinoma cells [169,209]. The gene discussed is PDPN; the disease is lip and oral cavity carcinoma.